FDA Label for Glycerin Laxative
View Indications, Usage & Precautions
Glycerin Laxative Product Label
The following document was submitted to the FDA by the labeler of this product Neilmed Pharmaceuticals Inc.. The document includes published materials associated whith this product with the essential scientific information about this product as well as other prescribing information. Product labels may durg indications and usage, generic names, contraindications, active ingredients, strength dosage, routes of administration, appearance, warnings, inactive ingredients, etc.
Drug Facts
Active ingredient (in each suppository)
Glycerin, USP 2 grams
Purpose
Active ingredient (in each suppository) ...............Purpose
Glycerin, USP 2 grams ...................................... Laxative
Uses
• relieves occasional constipation (irregularity)
• generally produces bowel movement in ¼ to 1 hour
Warnings
For rectal use only
Do Not Use
laxative products for longer than 1 week unless directed by a doctor
Ask A Doctor Before Use If You Have
• stomach pain • nausea • vomiting • noticed a sudden change in bowel habits that lasts over 2 weeks
When Using This Product
you may have rectal discomfort or a burning sensation
Stop Use And Ask A Doctor If
you have rectal bleeding or fail to have a bowel movement after use of a laxative.
These could be signs of a serious condition.
If Pregnant Or Breast-Feeding,
ask a health professional before use.
Keep Out Of Reach Of Children.
If swallowed, get medical help or contact a Poison Control Center right away.
Directions
adults and children 6 years of age and over : insert 1 suppository well into the rectum and retain for 15 minutes; it need not melt to produce laxative action. Do not exceed 1 suppository daily or as directed by a doctor.
children 2 to under 6 years: use Child Suppositories
children under 2 years: ask a doctor
Other Information
• keep tightly closed • avoid excessive heat
Inactive Ingredients:
purified water, sodium hydroxide, stearic acid
Package Label.Principal Display Panel
* Please review the disclaimer below.